Form 4: Bristol Myers Squibb Director Receives Stock Grant
Insider Transaction (Form 4)
Michael R. Mcmullen, a Director of Bristol Myers Squibb Co, received 561 shares of common stock on September 30, 2026.
Summary
- Grant/award: acquired 561 Deferred Share Units at $62.40 ($35,000) on September 30, 2026; holds 17,051 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Michael R. Mcmullen — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Grant/award | Deferred Share Units | 560.897 | $62 | $35.0K | 17,050.601 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Grant/award (561 shares) |
Keywords
insider transaction, Form 4, BMY, BRISTOL MYERS SQUIBB CO, neutral, Michael R. Mcmullen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.